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Abstract
Objectives—To evaluate, in extremely low gestational age newborns (ELGANs), relationships 
between indicators of early postnatal hypotension and cranial ultrasound indicators of cerebral 
white matter damage imaged in the nursery and cerebral palsy diagnoses at 24 month follow-up.
Methods—The 1041 infants in this prospective study were born at < 28 weeks gestation, were 
assessed for 3 indicators of hypotension in the first 24 postnatal hours, had at least one set of 
protocol cranial ultrasound scans, and were evaluated with a structured neurologic exam at 24 
months corrected age. Indicators of hypotension included: 1) lowest mean arterial pressure (MAP) 
in the lowest quartile for gestational age; 2) treatment with a vasopressor; and 3) blood pressure 
lability, defined as the upper quartile of the difference between each infant’s lowest and highest 
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MAP. Outcomes included indicators of cerebral white matter damage, i.e. moderate/severe 
ventriculomegaly or an echolucent lesion on cranial ultrasound, and cerebral palsy diagnoses at 24 
months gestation. Logistic regression was used to evaluate relationships among hypotension 
indicators and outcomes, adjusting for potential confounders.
Results—Twenty-one percent of surviving infants had a lowest blood pressure in the lowest 
quartile for gestational age, 24% were treated with vasopressors, and 24% had labile blood 
pressure. Among infants with these hypotension indicators, 10% percent developed 
ventriculomegaly and 7% developed an echolucent lesion. At 24-months follow-up, 6% had 
developed quadriparesis, 4% diparesis, and 2% hemiparesis. After adjusting for confounders, we 
found no association between indicators of hypotension, and indicators of cerebral white matter 
damage or a cerebral palsy diagnosis.
Conclusions—The absence of an association between indicators of hypotension and cerebral 
white matter damage and or cerebral palsy suggests that early hypotension may not be important 
in the pathogenesis of brain injury in ELGANs.
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Introduction
In a multi-center study, we found that more than 80% of extremely low gestational age 
newborns (ELGANs) were given some treatment to increase blood pressure,1 perhaps 
because it has been posited that hypotension causes brain damage in preterm newborns.2 
One indicator of brain damage, cranial ultrasound abnormalities, has been associated with 
systemic hypotension in several studies. 3–9 However, the majority of published studies 
found no such association.10–22 Conflicting results have also been obtained from studies of 
the association between hypotension and cerebral palsy.22–25 Moreover, there appears to be 
uncertainty about whether treatments for hypotension in preterm newborns are beneficial or 
harmful.9, 21 In summary, the literature is unclear about the relationship between systemic 
hypotension, its treatment, and brain damage in preterm newborns.
The ELGAN Study provided the opportunity to evaluate relationships between three 
indicators of hypotension during the first 24 postnatal hours, cranial ultrasound lesions 
observed during initial hospitalization, and a cerebral palsy diagnosis 24 months later.
Methods
The ELGAN Study was designed to identify characteristics and exposures that increase the 
risk of structural and functional neurological disorders in ELGANs (Extremely Low 
Gestational Age Newborns).26 During the years 2002–2004, women whose babies were 
delivered before 28 weeks gestation at one of 14 participating institutions were asked to 
enroll in the study. The project was overseen by the National Institutes of Health, the 
institutional review boards of the 14 participating institutions, and an external Performance 
Monitoring and Safety Board (members appointed by the National Institutes of Neurologic 
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Disorders and Stroke) at Children’s Hospital Boston. All variables and outcomes were 
defined prospectively. The original ELGAN Study included training for research personnel 
prior to the start of the study, and multiple training sessions were held to ensure consistent 
approaches to data collection. As such, this is a secondary analysis of prospectively acquired 
data from the original sample of 1506 infants, born in 14 level III neonatal intensive care 
units in the United States.
The sample of 1041 infants who are the subjects of this analysis had all three day-1 
hypotension measures, one or more protocol ultrasound sets, and a neurologic exam at 24 
months corrected age (Figure 1). To assess bias, we compared characteristics of the infants 
who returned for a developmental assessment to those of the 142 infants who were eligible 
but did not return. Infants who returned for 24 month follow-up tended to be born later in 
gestation but were more likely to have one of the indicators of hypotension.
Demographic, pregnancy and delivery variables
The clinical circumstances that led to each maternal admission and ultimately to each 
preterm delivery were operationally defined using data from a structured maternal interview 
and data abstracted from the medical record.27 Characteristics and exposures which were 
evaluated as potential confounders are shown in Table 2.
Newborn variables
Gestational age estimates were based on a hierarchy of the quality of available information. 
Most desirable were estimates based on the dates of embryo retrieval, intrauterine 
insemination or fetal ultrasound before the 14th week (62%). When these were not available, 
reliance was placed sequentially on a fetal ultrasound at 14 or more weeks (29%), date of the 
last menstrual period without fetal ultrasound (7%), and gestational age recorded in the log 
of the neonatal intensive care unit (1%). The birth weight Z-score and head circumference 
Z-score represent the number of standard deviations the infant’s weight or head 
circumference are above or below the mean of infants at the same gestational age in a 
standard data set.28
Hypotension indicators
The ELGAN Study recorded three mean arterial blood pressures--the lowest, highest, and 
mode (most common)--during the first 24 postnatal hours. Because no single definition of 
hypotension is widely accepted,1, 20 we examined three indicators of hypotension: 1) lowest 
mean arterial pressure (MAP) in the lowest quartile for gestational age (23–24, 25–26, and 
27 weeks); 2) treatment for hypotension with a vasopressor (dopamine, dobutamine, or 
epinephrine); and 3) blood pressure lability, defined as the upper quartile of the difference 
between the lowest and highest MAP.
The first definition of hypotension, “lowest MAP in the lowest quartile for gestational age” 
is based on the distribution of the lowest recorded MAPs in the sample. The second 
definition, “vasopressor treatment”, is an operational definition that derives from the 
assumption that hypotension was important enough to treat, regardless of how the clinician 
arrived at that decision. The third definition, “blood pressure lability”, makes use of the 
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lowest and highest blood pressures in the sample, and reflects the portion of the sample with 
the greatest variability in recorded MAPs.
Clinicians and researchers frequently use MAP (in mmHg) less than gestational age (in 
weeks) as a definition for hypotension.20, 29 Using that definition, approximately two-thirds 
of infants in this cohort were “hypotensive” making it difficult to evaluate its potential 
impact. Similarly, since 75% of the cohort received volume expansion in the first 24 
postnatal hours, volume expansion was not used as an indicator of hypotension in this study.
We did not specify a priori the method for measuring blood pressure (oscillometry or intra-
arterial catheter) or a frequency with which pressures were to be recorded and research 
personnel who abstracted data were unaware of the method.
Cranial ultrasound evaluation
In this sample of ELGANs, moderate/severe ventriculomegaly and an echolucent lesion 
were better predictors of cerebral palsy and developmental delay than echodensity.30, 31 In 
addition, the inter-reader agreement was higher for moderate/severe ventriculomegaly and 
an echolucent lesion than for echodensity.30 Therefore, we chose moderate/severe 
ventriculomegaly and an echolucent lesion as indicators of white matter damage; hereafter, 
all references to “indicators of white matter damage” indicate moderate/severe 
ventriculomegaly and/or an echolucent lesion on postnatal ultrasound.
The three sets of protocol scans were defined by the postnatal day on which they were 
obtained. Protocol 1 scans were obtained between the first and fourth day (N=784), protocol 
2 scans were obtained between the fifth and fourteenth day (N=973), and protocol 3 scans 
were obtained between the fifteenth day and the 40th week (N=1011). Seven hundred eleven 
infants in this sample of 1041 had all three sets of ultrasound studies.
Details about the methods for obtaining ultrasound scans, efforts to minimize observer 
variability, and strategies aimed at achieving concordance in the reading of the ultrasound 
scans are described elsewhere.32 All ultrasound scans were read by two independent 
sonologists who were not provided clinical information. When the two readers differed in 
their recognition of moderate/severe ventriculomegaly or an echolucent lesion, the films 
were sent to a third (tie-breaking) reader who was unaware of the first two sonologists 
reports.
Neurologic assessment
A developmental assessment was offered to all survivors at 24 months corrected gestational 
age. Of the study participants alive at 24 months, 88% were evaluated with a neurologic 
exam. The developmental assessment included a 31-item structured neurologic examination 
administered by staff who were trained and certified using a multi-media training video.33 
Due to the low frequency of non-spastic cerebral palsy in infants less than 2 years of age, we 
focused on the spastic forms of cerebral palsy (quadriparesis, diparesis, or hemiparesis) 
using a previously published algorithm.34 The referenced algorithm includes monoparesis 
under the classification hemiparesis, and triparesis under the classification quadriparesis.
Logan et al. Page 4














We evaluated the null hypothesis that infants with an indicator of hypotension during the 
first 24 postnatal hours were no more likely than their peers to have an indicator of white 
matter damage or a cerebral palsy diagnosis.
To identify potential confounders, we compared the distribution of characteristics and 
exposures among children who had each hypotension indicator to the distribution among 
those who did not. We then compared the distribution of these characteristics and exposures 
among children who did and did not have each of the outcomes.
Characteristics and exposures of the pregnancy, delivery, and postnatal period were treated 
as potential confounders if they had been considered potential confounders previously, or 
were associated in this dataset with both the exposure (a hypotension indicator) and the 
outcome (a cranial ultrasound lesion or cerebral palsy diagnosis) with a p-value ≤ 0.25. The 
only exception to the foregoing was that we did not treat SNAP-II (Score for Neonatal Acute 
Physiology-II) as a potential confounder because lowest MAP in the first 12 hours is a 
component of SNAP-II.35 We fit 15 separate multivariate logistic regression models, one for 
each of the five outcomes with each of the three hypotension indicators. In order to study the 
most homogeneous outcomes, we compared children with each CP diagnosis to those 
without CP. Each model included a hospital strata term to account for the possibility that 
infants born at a particular hospital were more like each other than like infants born at other 
hospitals. We describe the strength of the association between indicators of hypotension and 
indicators of white matter damage and cerebral palsy diagnosis, by calculating odds ratios 
(OR) and 95% confidence intervals (CIs), adjusting for confounders.
Results
For the parent study sample of 1506 infants, hypotension measures and cranial ultrasound 
scans were available for 1411 (94%). At 24 months adjusted age, 1183 (84%) of these 
infants were alive, and 1041 (88%) of these were evaluated with the structured neurologic 
exam (Figure 1). To evaluate whether there was bias due to the exclusion of the 142 infants 
lost to follow-up, we compared characteristics of mothers and infants who returned for a 
developmental assessment to those of mothers and infants who were eligible but did not 
return. Infants who returned for 24 month follow-up tended to be born to mothers with at 
least a college education, and were more likely to have a hypotension indicator (Table 1).
While the frequency of lowest blood pressure in the lowest quartile was 25% for the entire 
cohort, it was only 21% in the cohort for these analyses. Twenty-four percent were treated 
with vasopressor, and 24% had labile blood pressure. In the NICU, 10% developed 
moderate/severe ventriculomegaly and 7% developed an echolucent lesion. At 24-months, 
6% had developed quadriparesis, 4% diparesis, and 2% hemiparesis.
Social, demographic, and pregnancy characteristics (Table 2)
We created Tables 1 and 2 to examine potential confounders of relationships between 
indicators of hypotension and indicators of cerebral white matter damage and cerebral palsy 
diagnoses. Black race and public insurance were associated with a slightly higher rate of 
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blood pressure lability, but infants whose mother had these characteristics were no more 
likely than their peers to develop cranial ultrasound lesions or a cerebral palsy diagnosis. 
Infants of multi-fetal gestation were more likely singletons to receive vasopressors, but were 
no more likely than their peers to develop one of the outcomes of interest. Maternal vaginitis 
was associated with blood pressure lability and with both ventriculomegaly and 
quadriplegia. Similarly, infants whose mothers used aspirin were more likely to have 
received vasopressors and more likely to develop ventriculomegaly, an echolucent lesion, 
and quadriplegia. However, these associations were based only on 57 women-infant dyads 
exposed to antenatal aspirin. Infants exposed antenatally to magnesium had lower risks of 
blood pressure in the lowest quartile for gestational age, and were less likely to develop 
ventriculomegaly, an echolucent lesion, quadriparesis, and hemiparesis.
Infant characteristics (Table 3)
Infants of low gestational age were more likely than their gestationally-older peers to receive 
vasopressors and to have labile blood pressure, and were slightly more likely to develop 
ventriculomegaly, an echolucent lesion, or a cerebral palsy diagnosis. A birth weight Z-score 
< -1 was associated with both labile blood pressure and hemiparesis.
Univariate relationships among hypotension indicators, indicators of white matter damage 
and cerebral palsy diagnoses. (Table 4)
The indicators of hypotension are highly related. Among children with a lowest blood 
pressure in the lowest quartile for gestation, 44% received a vasopressor, and 42% had labile 
blood pressure. In contrast, among those who did not have a blood pressure in the lowest 
quartile for gestational age, only 19% received a vasopressor and 19% had labile blood 
pressure.
Multivariate relationship (Figures 2 and 3)
Univariate analyses (Tables 2 and 3) identified black race, public insurance, primigravida, 
male sex, gestational age 23–24 weeks, birthweight Z-score < -1, multi-fetal pregnancy, 
delivery for preeclampsia or fetal indication, receipt of magnesium, and SNAP-II, as 
potential confounders. After adjusting for confounders, we found no association between 
any of the three indicators of hypotension and the two indicators of white matter damage 
(figure 2) or any of three cerebral palsy diagnoses (figure 3). SNAP-II was not included in 
multivariate analyses for the reasons cited in the Data analysis section.
Discussion
In a large sample of ELGANs, we found little evidence for an association between 
hypotension indicators and indicators of white matter damage or a cerebral palsy diagnosis. 
Our findings cast doubt on the concept that early postnatal hypotension, in isolation, causes 
brain damage in ELGANs. In addition, we did not find support for the notion that 
vasopressors benefit preterm neonates with early postnatal hypotension.36
Prior studies favoring an association between hypotension and brain ultrasound lesions3–9 
had relatively small sample sizes, decreasing the likelihood that potential confounders could 
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be adequately controlled. Most of the studies favoring an association between hypotension 
and cerebral palsy acquired data retrospectively, 9, 21, 23, 24 increasing the possibility of 
ascertainment bias, and the one prospective study with a design comparable to ours failed to 
demonstrate such an association.25 Our findings are in agreement with the majority of 
published studies, which found no convincing relationship between hypotension and brain 
ultrasound images10–22 or cerebral palsy.22, 25
The hypothesis that “early postnatal hypotension causes white matter damage in preterm 
infants” is predicated on two related concepts. The first is that cerebral white matter damage 
is a consequence of ischemia. The second is that ischemia results from systemic 
hypotension. Since the late 1970s, when Hans Lou published his historically important 
studies of preterm infants, in which early systemic hypotension was correlated with low 
cerebral blood flow and brain injury, neonatologists have been concerned about the adverse 
effects of early systemic hypotension on the fragile preterm brain.37, 38 Since that time, it 
has become increasingly clear that the etiology of brain damage in preterm newborns is 
multifactorial.15, 39, 40 Our study and others suggest that systemic hypotension, as an 
isolated clinical event, is an insufficient indicator of white matter damage in preterm 
newborns, and by extension, an insufficient indicator of cerebral ischemia.
We offer a number of possible explanations for why early postnatal hypotension might not 
increase the risk of white matter damage or cerebral palsy in extremely preterm infants. 
First, a relatively low blood pressure on the first day of life might be part of the normal 
physiologic transition from intrauterine to extrauterine life. Second, “hypotension”, as 
described here, might not lead to cerebral ischemia. Third, if “hypotension” does cause 
ischemia, then it does not occur with enough frequency or severity to be associated with 
white matter damage or cerebral palsy at 2 years. Fourth, if hypotension is associated with 
white matter damage, then our crude methods for obtaining blood pressure measurements 
are insufficient for clinical decision-making regarding cerebral perfusion.
Our study has several limitations. First, we did not pre-specify a protocol for measuring 
blood pressure; some measurements were obtained by intra-arterial catheters, while others 
were obtained by oscillometry. Overestimates of blood pressure, which frequently 
accompany the use of oscillometry, might have attenuated associations between hypotension 
indicators and ultrasound lesions or cerebral palsy.41, 42 Second, our findings may have been 
confounded by the frequent use of volume expansion. Any inferences from our findings 
should be limited to cohorts in which volume expansion is used frequently, as three-fourths 
of study infants were treated with volume expansion in the first 24 postnatal hours. Third, 
we might have failed to identify hypotension-related white matter damage because cranial 
ultrasound fails to detect some of the white matter damage that is later identified with 
magnetic resonance imaging.43
The strengths of our study include the prospective collection of data from a large multicenter 
cohort, defined by gestational age (rather than birth weight).44 This study derives from a 
large sample of ELGANs from several regions of the United States, increasing the validity 
and generalizability of our findings.45, 46 We assessed brain damage using both structural 
and functional outcomes that were assessed with a high degree of reliability, enhancing the 
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validity of these assessments. In addition, the identification of ultrasound lesions required 
the agreement of two independent readers, decreasing the likelihood of inter-observer 
variability. Finally, follow up data were collected by examiners trained in the standardized 
administration of the neurologic exam, and these examiners were unaware of the child’s 
clinical history.33
Prior studies that provided evidence for an association between low blood pressure and 
white matter damage or cerebral palsy were smaller than ours, and less likely to adequately 
adjust for confounders. This underscores the importance of our findings, as prior “positive” 
studies, may have created a distorted perception of the strength of antecedent risks.45, 46 
Thus, we support the recommendation of others, that randomized trials be used to evaluate 
the benefit of treatments to raise blood pressure in extremely preterm neonates.47 Perhaps 
the most important implication for clinicians is that our study and others fail to find support 
for the hypothesis that white matter damage is associated with low blood pressure in the 
early postnatal period.
In conclusion, in a cohort of preterm infants, the majority of whom were treated with 
volume expanders, we found little evidence for an association between early indicators of 
postnatal hypotension and two indicators of cerebral white matter damage and cerebral palsy 
diagnoses at 24 months corrected gestational age.
Abbreviations
ELGAN extremely low gestational age newborn
IVH intraventricular hemorrhage




1. Laughon M, Bose C, Allred E, et al. Factors associated with treatment for hypotension in extremely 
low gestational age newborns during the first postnatal week. Pediatrics. 2007; 119:273–80. 
[PubMed: 17272616] 
2. du Plessis AJ. The role of systemic hemodynamic disturbances in prematurity-related brain injury. J 
Child Neurol. 2009; 24:1127–40. [PubMed: 19745087] 
3. Weindling AM, Wilkinson AR, Cook J, et al. Perinatal events which precede periventricular 
haemorrhage and leukomalacia in the newborn. Br J Obstet Gynaecol. 1985; 92:1218–23. [PubMed: 
3910079] 
4. Miall-Allen VM, de Vries LS, Whitelaw AG. Mean arterial blood pressure and neonatal cerebral 
lesions. Arch Dis Child. 1987; 62:1068–9. [PubMed: 3314723] 
5. Watkins AM, West CR, Cooke RW. Blood pressure and cerebral haemorrhage and ischaemia in 
very low birthweight infants. Early Hum Dev. 1989; 19:103–10. [PubMed: 2737101] 
6. Fok TF, Davies DP, Ng HK. A study of periventricular haemorrhage, post-haemorrhagic ventricular 
dilatation and periventricular leucomalacia in chinese preterm infants. J Paediatr Child Health. 
1990; 26:271–5. [PubMed: 2265019] 
Logan et al. Page 8













7. Low JA, Froese AB, Galbraith RS, et al. The association between preterm newborn hypotension and 
hypoxemia and outcome during the first year. Acta Paediatr. 1993; 82:433–7. [PubMed: 7686060] 
8. O’Shea TM, Kothadia JM, Roberts DD, et al. Perinatal events and the risk of intraparenchymal 
echodensity in very-low-birthweight neonates. Paediatr Perinat Epidemiol. 1998; 12:408–21. 
[PubMed: 9805714] 
9. Kuint J, Barak M, Morag I, et al. Early treated hypotension and outcome in very low birth weight 
infants. Neonatology. 2008; 95:311–316. [PubMed: 19052477] 
10. Trounce JQ, Shaw DE, Levene MI, et al. Clinical risk factors and periventricular leucomalacia. 
Arch Dis Child. 1988; 63:17–22. [PubMed: 3348645] 
11. de Vries LS, Regev R, Dubowitz LM, et al. Perinatal risk factors for the development of extensive 
cystic leukomalacia. Am J Dis Child. 1988; 142:732–5. [PubMed: 3289372] 
12. Bejar RF, Vaucher YE, Benirschke K, et al. Postnatal white matter necrosis in preterm infants. J 
Perinatol. 1992; 12:3–8. [PubMed: 1560287] 
13. Gronlund JU, Korvenranta H, Kero P, et al. Elevated arterial blood pressure is associated with peri-
intraventricular haemorrhage. Eur J Pediatr. 1994; 153:836–41. [PubMed: 7843200] 
14. D’Souza SW, Janakova H, Minors D, et al. Blood pressure, heart rate, and skin temperature in 
preterm infants: Associations with periventricular haemorrhage. Arch Dis Child Fetal Neonatal 
Ed. 1995; 72:F162–7. [PubMed: 7796230] 
15. Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature 
infant: Associated risk factors. Pediatrics. 1996; 97:822–7. [PubMed: 8657521] 
16. Wiswell TE, Graziani LJ, Kornhauser MS, et al. Effects of hypocarbia on the development of 
cystic periventricular leukomalacia in premature infants treated with high-frequency jet 
ventilation. Pediatrics. 1996; 98:918–24. [PubMed: 8909486] 
17. Baud O, Ville Y, Zupan V, et al. Are neonatal brain lesions due to intrauterine infection related to 
mode of delivery? Br J Obstet Gynaecol. 1998; 105:121–4. [PubMed: 9442175] 
18. Cunningham S, Symon AG, Elton RA, et al. Intra-arterial blood pressure reference ranges, death 
and morbidity in very low birthweight infants during the first seven days of life. Early Hum Dev. 
1999; 56:151–65. [PubMed: 10636594] 
19. Dammann O, Allred EN, Kuban KC, et al. Systemic hypotension and white-matter damage in 
preterm infants. Dev Med Child Neurol. 2002; 44:82–90. [PubMed: 11852927] 
20. Limperopoulos C, Bassan H, Kalish LA, et al. Current definitions of hypotension do not predict 
abnormal cranial ultrasound findings in preterm infants. Pediatrics. 2007; 120:966–77. [PubMed: 
17974733] 
21. Batton B, Zhu X, Fanaroff J, et al. Blood pressure, anti-hypotensive therapy, and 
neurodevelopment in extremely preterm infants. J Pediatr. 2008 First published online Nov 19 
2008. 
22. Pellicer A, del Carmen Bravo M, Madero R, et al. Early systemic hypotension and vasopressor 
support in low birth weight infants: Impact on neurodevelopment. Pediatrics. 2009; 123:1369–76. 
[PubMed: 19403504] 
23. Goldstein RF, Thompson RJ Jr, Oehler JM, et al. Influence of acidosis, hypoxemia, and 
hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics. 1995; 
95:238–43. [PubMed: 7530835] 
24. Murphy DJ, Hope PL, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: 
Case-control study. BMJ. 1997; 314:404–8. [PubMed: 9040385] 
25. Hunt RW, Evans N, Rieger I, et al. Low superior vena cava flow and neurodevelopment at 3 years 
in very preterm infants. J Pediatr. 2004; 145:588–92. [PubMed: 15520755] 
26. O’Shea TM, Allred EN, Dammann O, et al. The ELGAN study of the brain and related disorders in 
extremely low gestational age newborns. Early Hum Dev. 2009; 85:719–25. [PubMed: 19765918] 
27. McElrath TF, Hecht JL, Dammann O, et al. Pregnancy disorders that lead to delivery before the 
28th week of gestation: An epidemiologic approach to classification. Am J Epidemiol. 2008; 
27:27.
28. Yudkin PL, Aboualfa M, Eyre JA, et al. New birthweight and head circumference centiles for 
gestational ages 24 to 42 weeks. Early Hum Dev. 1987; 15:45–52. [PubMed: 3816638] 
Logan et al. Page 9













29. Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive 
very low birth weight infant. J Perinatol. 2006; 26:677–81. [PubMed: 16929346] 
30. O’Shea TM, Kuban KC, Allred EN, et al. Neonatal cranial ultrasound lesions and developmental 
delays at 2 years of age among extremely low gestational age children. Pediatrics. 2008; 
122:e662–9. [PubMed: 18762501] 
31. Kuban KC, Allred EN, O’Shea TM, et al. Cranial ultrasound lesions in the NICU predict cerebral 
palsy at age 2 years in children born at extremely low gestational age. J Child Neurol. 2009; 
24:63–72. [PubMed: 19168819] 
32. Kuban K, Adler I, Allred EN, et al. Observer variability assessing US scans of the preterm brain: 
The elgan study. Pediatr Radiol. 2007; 37:1201–8. [PubMed: 17901950] 
33. Kuban KC, O’Shea M, Allred E, et al. Video and CD-ROM as a training tool for performing 
neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child 
Neurol. 2005; 20:829–31. [PubMed: 16417880] 
34. Kuban KC, Allred EN, O’Shea M, et al. An algorithm for identifying and classifying cerebral palsy 
in young children. J Pediatr. 2008; 153:466–72. [PubMed: 18534210] 
35. Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-II and SNAPPE-II: Simplified newborn 
illness severity and mortality risk scores. J Pediatr. 2001; 138:92–100. [PubMed: 11148519] 
36. Dempsey EM, Barrington KJ. Evaluation and treatment of hypotension in the preterm infant. Clin 
Perinatol. 2009; 36:75–85. [PubMed: 19161866] 
37. Lou HC, Lassen NA, Friis-Hansen B. Low cerebral blood flow in hypotensive perinatal distress. 
Acta Neurol Scand. 1977; 56:343–52. [PubMed: 920113] 
38. Lou HC, Lassen NA, Friis-Hansen B. Impaired autoregulation of cerebral blood flow in the 
distressed newborn infant. J Pediatr. 1979; 94:118–21. [PubMed: 758388] 
39. Leviton A, Pagano M, Kuban KC, et al. The epidemiology of germinal matrix hemorrhage during 
the first half-day of life. Dev Med Child Neurol. 1991; 33:138–45. [PubMed: 2015981] 
40. Collins MP, Lorenz JM, Jetton JR, et al. Hypocapnia and other ventilation-related risk factors for 
cerebral palsy in low birth weight infants. Pediatr Res. 2001; 50:712–9. [PubMed: 11726729] 
41. O’Shea J, Dempsey EM. A comparison of blood pressure measurements in newborns. Am J 
Perinatol. 2009; 26:113–6. [PubMed: 19021094] 
42. Troy R, Doron M, Laughon M, et al. Comparison of noninvasive and central arterial blood 
pressure measurements in elbw infants. J Perinatol. 2009; 29:744–9. [PubMed: 19609309] 
43. Inder TE, Anderson NJ, Spencer C, et al. White matter injury in the premature infant: A 
comparison between serial cranial sonographic and MR findings at term. AJNR Am J Neuroradiol. 
2003; 24:805–9. [PubMed: 12748075] 
44. Arnold CC, Kramer MS, Hobbs CA, et al. Very low birth weight: A problematic cohort for 
epidemiologic studies of very small or immature neonates. Am J Epidemiol. 1991; 134:604–13. 
[PubMed: 1951265] 
45. Dickersin K. The existence of publication bias and risk factors for its occurrence. Jama. 1990; 
263:1385–9. [PubMed: 2406472] 
46. Hall R, de Antueno C, Webber A. Publication bias in the medical literature: A review by a 
canadian research ethics board. Can J Anaesth. 2007; 54:380–8. [PubMed: 17470890] 
47. Dempsey EM, Barrington KJ. Treating hypotension in the preterm infant: When and with what: A 
critical and systematic review. J Perinatol. 2007; 27:469–78. [PubMed: 17653217] 
Participating institutions (site principal investigators, sonologists, and 
neuro-developmental examiners)
Baystate Medical Center, Springfield MA (Bhavesh Shah, Frederick Hampf, Herbert 
Gilmore, Susan McQuiston)
Beth Israel Deaconess Medical Center, Boston MA (Camilia R. Martin, Jane Share)
Logan et al. Page 10













Brigham & Women’s Hospital, Boston MA (Linda J. Van Marter, Sara Durfee)
Children’s Hospital Boston, Boston MA (Alan Leviton, Kristen Ecklund, Samantha Butler, 
Haim Bassan, Adré Duplessis, Cecil Hahn, Omar Khwaha, AK Morgan, Janet S. Soul)
DeVos Children’s Hospital, Grand Rapids MI (Mariel Portenga, Bradford W. Betz, Steven 
L. Bezinque, Joseph Junewick, Wendy Burdo-Hartman, Lynn Fagerman, Kim Lohr, Steve 
Pastynrnak, Dinah Sutton)
Floating Hospital for Children at Tufts Medical Center, Boston MA (Cynthia Cole/John 
Fiascone, Roy McCauley, Paige T. Church, Cecelia Keller, Karen Miller)
Massachusetts General Hospital, Boston MA (Robert Insoft, Kalpathy Krishnamoorthy)
Michigan State Univeristy, E Lansing MI (Nigel Paneth)
North Carolina Children’s Hospital, Chapel Hill NC (Carl Bose, Lynn A. Fordham, Lisa 
Bostic, Janice Wereszczak, Diane Marshall, Kristi Milowic, Carol Hubbard)
Sparrow Hospital, Lansing MI (Padmani Karna, Ellen Cavenagh, Victoria J. Caine, Padmani 
Karna, Nicholas Olomu, Joan Price)
University of Chicago Hospital, Chicago IL (Michael D. Schreiber, Kate Feinstein, Leslie 
Caldarelli, Sunila E. O’Conno, Michael Msall, Susan Plesha-Troyke)
University Health Systems of Eastern Carolina, Greenville NC (Stephen Engelke, Ira Adler, 
Sharon Buckwald, Rebecca Helms, Kathyrn Kerkering, Scott S. MacGilvray, Peter Resnik)
U Mass Memorial Health Center, Worcester, MA (Francis Bednarek, Jacqueline Wellman, 
Robin Adair, Richard Bream, Alice Miller, Albert Scheiner, Christy Stine)
Wake Forest University Baptist Medical Center and Forsyth Medical Center, Winston-
Salem NC (T. Michael O’Shea, Barbara Specter, Deborah Allred, Don Goldstein, Gail 
Hounshell, Robert Dillard, Cherrie Heller, Debbie Hiatt, Lisa Washburn)
William Beaumont Hospital, Royal Oak MI (Daniel Batton, Chung-ho Chang, Karen 
Brooklier, Melisa Oca)
Yale University School of Medicine, New Haven CT (Richard Ehrenkranz, Cindy Miller, 
Nancy Close, Elaine Romano, Joanne Williams)
Logan et al. Page 11














Sample for analyses of hypotension indicators and ultrasound lesions and cerebral palsy
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Odds ratios (and 95% confidence intervals) of the risk of indicators of white matter damage 
obtained with logistic regression models that incorporate indicators of hypotension during 
the first 24 postnatal hours and potential confounders.*
*Adjustment is made for black race, public insurance, primagravida, male sex, gestational 
age 23–24 weeks, birth weight Z-score < -1, multi-fetal gestation, delivery for preeclampsia 
or fetal indication and receipt of magnesium. A hospital strata term is included to account 
for the possibility that infants born at a particular hospital are more like each other than like 
infants born at other hospitals.
§Low Q: lowest MAP recorded in the first 24 hours in the lowest quartile for gestational age
¶Vaso: treatment for hypotension with a vasopressor in the first 24 hours with any 
vasopressor (dopamine, dobutamine, and epinephrine)
†Labile: labile blood pressure, defined as the upper quartile of the difference in the lowest 
and highest MAP
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Odds ratios (and 95% confidence intervals) of the risk of cerebral palsy types obtained with 
logistic regression models that incorporate indicators of hypotension during the first 24 
postnatal hours and potential confounders.*
*Adjustment is made for black race, public insurance, primagravida, male sex, gestational 
age 23–24 weeks, birth weight Z-score < -1, multi-fetal gestation, delivery for preeclampsia 
or fetal indication and receipt of magnesium. A hospital strata term is included to account 
for the possibility that infants born at a particular hospital are more like each other than like 
infants born at other hospitals.
§Low Q: lowest MAP recorded in the first 24 hours in the lowest quartile for gestational age
¶Vaso: treatment for hypotension with a vasopressor in the first 24 hours with any 
vasopressor (dopamine, dobutamine, and epinephrine)
†Labile: labile blood pressure, defined as the upper quartile of the difference in the lowest 
and highest MAP
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Table 1
Characteristics of mothers and children who survived to 24 months adjusted age, comparing those included in 
this study and those not included (column percents).
Maternal or infant characteristic Included in study Not included
Maternal education College or more 34 22
HMO/private insurance Yes 62 54
10+ prenatal care visits Yes 30 27
Conception assistance Yes 22 17
White race Yes 59 54
Antenatal corticosteroid Complete course 65 57
Partial Course 25 35
None 11 7
Cesarean delivery Yes 66 65
Sex Male 52 52
Gestational age (weeks) 23–24 20 23
25–26 46 47
27 34 30
Birth weight (grams) ≤ 750 37 37
751–1000 44 38
> 1000 19 25
Ventriculomegaly Yes 10 8
Echolucent lesion Yes 7 5
Lowest quartile MAP Yes 21 15
Vasopressor Yes 24 21
Labile MAP Yes 24 18
Maximum number of infants 1041 142
§
Lowest quartile MAP: lowest MAP recorded in the first 24 hours, in the lowest quartile for gestational age
¶
Vasopressor: treatment for hypotension in the first 24 hours, using any vasopressor (dopamine, dobutamine, epinephrine)
†
Labile MAP: labile blood pressure, defined as the upper quartile of the difference between the lowest and highest MAP
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